$GERN
Geron Corp
XNAS•Health Care•Pharmaceutical Preparations
$1.35
▲+4.38%+$0.056
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is GERN up today? It is at $1.35 (+4.38%), and our scanner flagged it 127 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GERN spikes, and full due diligence on GERN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $GERN 127 times in the last 30 days. Create a free account to track $GERN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on GERN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GERN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Spiegel Robert J. Director | Acquired (grant/award) | +6K | added 3.1% | 206K | $8K at $1.28 | Jun 30, 26 |
Spiegel Robert J. Director | Acquired (grant/award) | +5K | added 2.7% | 200K | $8K at $1.49 | Mar 31, 26 |
Robertson Michelle Officer | Sold (automatic/other) | -10K | sold 36% | 18K | $19K at $1.94 | Feb 18, 26 |
Robertson Michelle Officer | Other | 28K | n/a | 28K | n/a | Feb 18, 26 |
Spiegel Robert J. Director | Acquired (grant/award) | +6K | added 3.1% | 194K | $8K at $1.32 | Dec 31, 25 |
Spiegel Robert J. Director | Acquired (grant/award) | +6K | added 3.1% | 189K | $8K at $1.37 | Sep 30, 25 |
Spiegel Robert J. Director | Acquired (grant/award) | +6K | added 3.1% | 183K | $8K at $1.41 | Jun 30, 25 |
Lawlis V Bryan Director | Bought (open market) | +13K | n/a | 13K | $16K at $1.18 | May 9, 25 |
Spiegel Robert J. Director | Acquired (grant/award) | +5K | added 2.8% | 177K | $8K at $1.59 | Mar 31, 25 |
Samuels Scott Alan Officer | Bought (open market) | +15K | added 100% | 27K | $24K at $1.61 | Feb 27, 25 |
Scarlett John A Officer | Bought (open market) | +13K | n/a | 13K | $22K at $1.76 | Feb 27, 25 |
Ziegler James Officer | Bought (open market) | +100K 0.02% of company | n/a | 100K | $160K at $1.60 | Feb 27, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on GERN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GERN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
GERN last traded at $1.35, up 4.38% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Geron Corp (GERN) is next expected to report earnings on Wednesday, November 4, 2026, about 48 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The GERN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GERN 127 times in the last 30 days.
GERN (Geron Corp) trades on XNAS, with a market cap of about $829M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GERN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$GERN discussion
Sign in to ask a question or join the discussion.